Adlore is Therapeutic Devices in United States that focus on convenient health business. Founded in 2019. They cover business area such as developer, ulcerated wound treatment device, convenient health and optimal function, people, proprietary technology, heat, thermo-regulate electrical pulse stimulation, blood flow, performance, an application, individual, their well-being, health care cost.
2019
( 5 years old in 2024 )
Convenient Health
-
350 East Michigan Avenue
Suite 500
Kalamazoo, MI 49007
United States
Private
developerulcerated wound treatment deviceconvenient health and optimal functionpeopleproprietary technologyheat, thermo-regulate electrical pulse stimulationblood flowperformancean applicationindividualtheir well-beinghealth care cost
* We use standard office opening hours in near Adlore's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Adlore is Therapeutic Devices business from United States that founded in 2019 (5 years old in 2024), Adlore business is focusing on Convenient Health.
Adlore headquarter office and corporate office address is located in 350 East Michigan Avenue Suite 500 Kalamazoo, MI 49007 United States.
Adlore was founded in United States.
In 2024, Adlore is currently focus on convenient health sector.
Above is snippet of Google Trends for "convenient health" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Adlore, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.